Natural Capsules (NATCAPSUQ) | Financial Analysis & Statements
Natural Capsules Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
452.0M
Gross Profit
216.3M
47.85%
Operating Income
-38.9M
-8.61%
Net Income
-55.8M
-12.35%
EPS (Diluted)
₹-5.40
Balance Sheet Metrics
Total Assets
4.2B
Total Liabilities
1.6B
Shareholders Equity
2.6B
Debt to Equity
0.63
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Natural Capsules Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.6B | 1.5B | 1.6B | 1.3B | 740.2M |
| Cost of Goods Sold | 884.3M | 823.6M | 819.1M | 614.9M | 377.6M |
| Gross Profit | 757.3M | 689.3M | 828.1M | 683.8M | 362.6M |
| Gross Margin % | 46.1% | 45.6% | 50.3% | 52.7% | 49.0% |
| Operating Expenses | |||||
| Research & Development | 16.0M | 20.8M | 23.9M | 21.2M | 9.8M |
| Selling, General & Administrative | 158.3M | 107.9M | 129.9M | 101.6M | 64.5M |
| Other Operating Expenses | 243.0M | 230.0M | 244.5M | 197.4M | 112.4M |
| Total Operating Expenses | 417.3M | 358.7M | 398.3M | 320.2M | 186.7M |
| Operating Income | 90.3M | 103.2M | 272.4M | 229.7M | 77.3M |
| Operating Margin % | 5.5% | 6.8% | 16.5% | 17.7% | 10.4% |
| Non-Operating Items | |||||
| Interest Income | 1.5M | 9.2M | 3.7M | 2.1M | 1.4M |
| Interest Expense | 63.1M | 51.3M | 34.1M | 19.6M | 3.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 27.9M | 80.5M | 249.9M | 193.9M | 91.6M |
| Income Tax | 21.7M | 25.0M | 65.5M | 54.7M | 22.4M |
| Effective Tax Rate % | 77.9% | 31.0% | 26.2% | 28.2% | 24.5% |
| Net Income | 6.2M | 55.5M | 184.5M | 139.1M | 69.1M |
| Net Margin % | 0.4% | 3.7% | 11.2% | 10.7% | 9.3% |
| Key Metrics | |||||
| EBITDA | 187.4M | 219.1M | 356.9M | 290.4M | 122.1M |
| EPS (Basic) | ₹0.63 | ₹6.25 | ₹19.86 | ₹19.84 | ₹11.09 |
| EPS (Diluted) | ₹0.63 | ₹6.25 | ₹19.86 | ₹19.84 | ₹11.09 |
| Basic Shares Outstanding | 9836000 | 9304000 | 9276000 | 7012000 | 6233000 |
| Diluted Shares Outstanding | 9836000 | 9304000 | 9276000 | 7012000 | 6233000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Natural Capsules Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 6.6M | 19.5M | 12.7M | 14.0M | 975.0K |
| Short-term Investments | 45.4M | 110.1M | 52.8M | 33.5M | 4.5M |
| Accounts Receivable | 622.4M | 544.7M | 521.3M | 263.0M | 267.0M |
| Inventory | 254.6M | 190.4M | 88.5M | 45.8M | 66.1M |
| Other Current Assets | 6.6M | 4.9M | 3.7M | 38.0M | 5.6M |
| Total Current Assets | 1.3B | 1.2B | 1.0B | 755.8M | 496.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 31.2M | 15.8M | 15.8M | 15.8M | 10.9M |
| Goodwill | -1.0K | 4.8M | 11.1M | 17.4M | 0 |
| Intangible Assets | -1.0K | 4.8M | 11.1M | 17.4M | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.0K | -1.0K | 1.0K | 1.0K | 1.0K |
| Total Non-Current Assets | 2.9B | 2.5B | 1.9B | 886.9M | 473.5M |
| Total Assets | 4.2B | 3.8B | 2.9B | 1.6B | 970.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 385.1M | 304.2M | 274.3M | 159.8M | 160.8M |
| Short-term Debt | 477.7M | 410.6M | 261.5M | 180.2M | 98.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 39.4M | 19.4M | 24.6M | 22.5M | 14.9M |
| Total Current Liabilities | 999.9M | 764.7M | 669.4M | 447.7M | 333.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 574.3M | 679.5M | 706.5M | 347.6M | 4.7M |
| Deferred Tax Liabilities | 42.5M | 33.0M | 27.7M | 16.8M | 9.6M |
| Other Non-Current Liabilities | -2.0K | - | 1.0K | -1.0K | 50.0K |
| Total Non-Current Liabilities | 622.0M | 712.5M | 735.7M | 365.3M | 15.5M |
| Total Liabilities | 1.6B | 1.5B | 1.4B | 813.0M | 349.4M |
| Equity | |||||
| Common Stock | 103.4M | 93.3M | 92.8M | 70.1M | 62.3M |
| Retained Earnings | 794.9M | 781.0M | 734.6M | 557.8M | 426.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.6B | 2.3B | 1.5B | 829.8M | 621.0M |
| Key Metrics | |||||
| Total Debt | 1.1B | 1.1B | 967.9M | 527.8M | 102.9M |
| Working Capital | 295.9M | 472.9M | 345.6M | 308.2M | 163.0M |
Balance Sheet Composition
Natural Capsules Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 27.9M | 80.5M | 249.9M | 193.9M | 91.9M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 2.9M | 1.1M | 0 | - | - |
| Working Capital Changes | 11.3M | -301.1M | -247.0M | -218.2M | -135.1M |
| Operating Cash Flow | 103.9M | -177.4M | 33.3M | -11.2M | -42.2M |
| Investing Activities | |||||
| Capital Expenditures | -446.3M | -714.1M | -1.1B | -443.0M | -164.1M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | 0 | -27.3M | 0 | -372.0K | 0 |
| Investment Sales | 0 | 0 | 372.0K | 0 | 77.4M |
| Investing Cash Flow | -446.3M | -741.4M | -1.1B | -443.4M | -86.7M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | -9.3M | -7.7M | -6.2M | -3.7M |
| Debt Issuance | - | 124.6M | 442.7M | 426.4M | 33.7M |
| Debt Repayment | -51.9M | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 226.5M | 870.9M | 911.5M | 498.0M | 63.6M |
| Free Cash Flow | -178.8M | -799.8M | -886.7M | -466.0M | -106.3M |
| Net Change in Cash | -116.0M | -47.9M | -111.6M | 43.4M | -65.3M |
Cash Flow Trend
Natural Capsules Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
337.98
Price to Book
0.71
Price to Sales
0.93
PEG Ratio
-0.05
Profitability Ratios
Profit Margin
-11.03%
Operating Margin
-17.72%
Return on Equity
0.24%
Return on Assets
0.15%
Financial Health
Current Ratio
1.19
Debt to Equity
45.69
Beta
-0.17
Per Share Data
EPS (TTM)
₹-18.51
Book Value per Share
₹219.30
Revenue per Share
₹182.24
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NATCAPSUQ | 1.6B | 337.98 | 0.71 | 0.24% | -11.03% | 45.69 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





